Stay updated on TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.

Latest updates to the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior Notice about government funding lapse and Revision: v3.4.1.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a JAMA Oncology 2024 publication citation related to TITAN-TCC. Updated the record to revision v3.4.1 and removed the Erratum entry for that publication.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now shows the glossary by default. The QC and FEAR Act-related labels have been standardized and the revision tag updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check49 days agoChange DetectedA publication citation in Publications (JAMA Oncol. 2024) was added and the same citation was removed, resulting in no net change to the page's content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section now includes Thuringia as a study site, and the HHS Vulnerability Disclosure link and the Thuringia Locations entry have been removed.SummaryDifference0.2%

Stay in the know with updates to TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.